Opiod Class Action

Nadine Bews

Well-Known Member
https://kmlaw.ca/cases/liability-for-opioid-epidemic/
Koskie Minsky LLP in Toronto commenced a class action against 28 major pharmaceutical companies (see below). The action was commenced on behalf of all persons in Canada who were prescribed and became addicted to opioids.

This class action seeks to include all persons in Canada, except for excluded person, who were prescribed Opioids and subsequently developed an addiction to Opioids.

"Opioids" means any product marketed by the Defendants which contained any substance from the family of synthetic narcotic pain medications which resemble naturally occurring opiates, including, but not limited to, codeine, morphine, hydromorphone and fentanyl.

"Family Law Class" and "Family Law Class Members" means all persons within Canada, except for excluded persons, who by reason of his or her relationship to a Class Member have standing pursuant to s. 61(1) of the Family Law Act, R.S.O. 1990, c. F.3, or equivalent legislation in other provinces and territories;

"Excluded Persons" means any person entitled to recover damages in the action bearing Court File Number 07-CV-343201CP and any officer or director of any of the Defendants.

The Statement of Claim, issued in the Ontario Superior Court of Justice on May 15, 2019, alleges that the 28 pharmaceutical companies commenced a campaign promoting the use of opioids for various chronic conditions in the 1990s, which led to widespread addiction among individuals who were prescribed those medications.

This action comes on the heels of medical findings that opioids are no more effective than NSAIDS at treating many chronic conditions for which they are routinely prescribed. The lawsuit alleges that manufactures knew of this limited efficacy, and the significant risk of addiction, but promoted their products for these uses anyway.

The claim alleges that the defendants conspired, and were negligent in their research, development, manufacture, testing, regulatory licencing, distribution, sale and marketing of opioids. The lawsuit seeks $1.1 billion in damages.

It would be helpful if you could respond to this email with the following information:

1. Your full name;

2. Name of the person the opioids were prescribed to;

a. What is the name of the prescribed opioid(s)?

b. In what year was the opioid prescription issued to you?

3. Which of the following pharmaceutical companies produced the opioids you were prescribed?

a. APOTEX INC.

b. APOTEX PHARMACEUTICAL HOLDINGS, INC

c. BRISTOL-MYERS SQUIBB CANADA 1959

d. BRISTOL-MYERS SQUIBB COMPANY

e. PALADIN LABS

f. ENDO PHARMACEUTICALS INC

g. ENDO INTERNATIONAL PLC

h. JANSSEN INC.

i. JOHNSON & JOHNSON

j. PHARMASCIENCE INC.

k. JODDES LIMITED

l. PRO DOC LIMITEE

m. THE JEAN COUTU GROUP (PJC) INC.

n. MYLAN PHARMACEUTICALS ULC

o. MYLAN N.V

p. PURDUE PHARMA INC.

q. PURDUE PHARMA L.P.

r. THE PURDUE FREDERICK COMPANY

s. PURDUE FREDERICK INC.

t. RANBAXY PHARMACEUTICALS CANADA INC.

u. SUN PHARMACEUTICAL INDUSTRIES LTD.

v. HIKMA LABS INC.

w. HIKMA PHARMACEUTICALS PLC

x. WEST-WARD COLUMBUS INC.

y. SANIS HEALTH INC.

z. SANDOZ CANADA INC.

aa. TEVA CANADA LIMITED

bb. TEVA PHARMACEUTICALS USA, INC.

cc. TEVA PHARMACEUTICAL INDUSTRIES LTD.

dd. ACTAVIS PHARMA COMPANY

ee. VALEANT CANADA LP/ VALEANT CANADA S.E.C.

ff. BAUSCH HEALTH COMPANIES INC.

gg. AMERISOURCEBERGEN CANADA CORPORATION

hh. KOHL & FRISCH DISTRIBUTION INC.

ii. NU-QUEST DISTRIBUTION INC.

jj. ABBOTT LABORATORIES INC.

kk. PROCURITY INC.

ll. Other, please specify:

4. Your telephone number;

5. Your complete mailing address;

6. Your email address;

7. Whether you would be willing and able to speak to our lawyers should we wish to obtain further information; and

8. Whether you would be willing and able to swear an affidavit?


If you would like to speak with a lawyer about these sensitive issues, please let us know and a lawyer will call you.


A copy of the statement of claim is available here: https://kmlaw.ca/wp-content/uploads/2019/05/Statement-of-Claim-Issued-May-15-2019.pdf

Should you have any further questions, please do not hesitate to contact us.

Regards,

Communications Department

Koskie Minsky LLP | Barristers & Solicitors

T 1 833 630 1776| F 416-204-2897 | E [email protected]

https://kmlaw.ca/cases/liability-for-opioid-epidemic/.
 

Indagrow

Well-Known Member
So they are going to give addicts a payout for getting them hooked? How long before every cent comes right back into their bank? I'd give myself a day
 

Blue back

Well-Known Member
Norco fucked my life up big fuckn time! Was snorting 20 10's a day at the end. Need a knee replacement. It's weed and ibuprofen now days
 

QUAD BREATH

Well-Known Member
https://globalnews.ca/news/5280201/opioid-crisis-lawsuit-canada/

"Canadian drug makers enriched themselves at the expense of vulnerable patients by illegally and deceptively promoting highly addictive opioids that have killed thousands in recent years, a proposed class action filed Wednesday asserts.

The untested statement of claim filed in Ontario Superior Court seeks more than $1.1 billion in various damages from almost two dozen companies, including some of the biggest pharmaceutical names in the country such as Apotex, Bristol-Myers Squibb, Johnson and Johnson and the Jean Coutu Group.

The suit, filed on behalf of patients who became addicted to prescribed opioids, also seeks a declaration that the companies were negligent in how they researched, developed and marketed opioids starting in the 1990s."

These crooks fuked my Mom. Stick it to em :finger:
 

Nadine Bews

Well-Known Member
ll. Other, please specify:
"Opioids" means any product marketed by the Defendants which contained any substance from the family of synthetic narcotic pain medications which resemble naturally occurring opiates, including, but not limited to, codeine, morphine, hydromorphone and fentanyl.
 

Nadine Bews

Well-Known Member
I spent the better part of 16 years on opiates....
Please register and prepare a Victim Impact Statement...these are very important and we must solicit as many as we can in order to determine the sub-classes so that nobody gets left behind and because valuable information can be obtained from such statements and they have been proven to be psychologically 'healing'.....this is the mistake that Conroy made with the Allard action, he failed to solicit Victim Impact Statements until September 2013 and filed the action 3 months later in November 2013...and he had the brilliant mind of Wilcox reviewing those statements received...no doubt that 50% of the patients got 'left out' because of Conroy's oversight to consider an 'address change'...
 

Nadine Bews

Well-Known Member
Too bad they cant bring back all the friends and family that overdosed on that bullshit.
Hello Grilled Cheese, You are correct and thank you for commenting on the 'elephant in the room'....If you have been impacted by the opiod dependency or by the death of a family member or loved one due to opiod prescription drugs, please prepare and send in a victim impact statement and speak on their and your own behalf because I do believe that this sub-class is huge and must be heard in order to properly determine the scope and magnitude of this tragedy for legal and historical purposes...this generation of victims of opiod pharmaceutical genocide is going to make others pale in comparison...If you do not speak up at this time on their behalf, those on the other side will not be heard...Nadine.
 

VIANARCHRIS

Well-Known Member
"Opioids" means any product marketed by the Defendants which contained any substance from the family of synthetic narcotic pain medications which resemble naturally occurring opiates, including, but not limited to, codeine, morphine, hydromorphone and fentanyl.
So SSRI's do not qualify...I'll sue those fuckers myself.
 
Top